a popular abortion pill will stay on the market for now but with significant restrictions a late night ruling by a federal appeals court hit pause on part of a lower Court ruling that suspended approval of and access to mifepristone but the three-judge panel on the fifth Circuit Court of Appeals allowed other pieces of that Texas ruling to stand blocking a roughly seven-year effort by the FDA to expand access to the drug and potentially setting up a showdown in the U.S Supreme Court among the restrictions a requirement for in-person doctors visits to obtain the medication blocking mifepristone from being sent to patients through the mail and limiting its use to the first seven weeks of pregnancy instead of the current 10.

New Jersey's Congressional members have been vocal on the issue GOP representative Chris Smith signing on with a group of 69 other Congressional Republicans backing the initial ruling from the federal judge in Texas while Democrat Mikey Cheryl today introduced legislation to prevent so-called judge shopping which is what critics claim was used in that case this decision is changing the rules around the use of mifepristone and ordering that the drug cannot be sent through the mail that incredibly harms access across the country I expect there will be additional legal developments in the coming days Bottom Line women's healthcare is historically and consistently undervalued and restricted and this decision is detrimental to reproductive Choice Nationwide